Key markers such as alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (β-HCG) are frequently elevated in NSGCT and correlate with more aggressive disease, offering insights into metastatic potential and overall tumor burden [37]. The gene discussed is AFP; the disease is neoplasm.